Tmunity Announces $100 Million Financing Round
On January 23, 2018, Tmunity, a private clinical-stage biotherapeutics company focused on delivering the full potential of next-generation T-cell immunotherapy, announced that it has completed a $100 million Series A round of financing led by Ping An Ventures. Wilson Sonsini Goodrich & Rosati represented Ping An Ventures in the transaction.
According to a press release, the investment will be used to advance and expand the business and operational structure of Tmunity to support the rapid translation, development, and manufacture of its portfolio of novel T-cell based immunotherapies for cancer treatment.
For additional information, please see Tmunity's press release.